Front Row Advisors’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-200
Closed -$7K 939
2022
Q1
$7K Hold
200
﹤0.01% 643
2021
Q4
$8K Buy
+200
New +$8K ﹤0.01% 638